After 64 weeks, adults taking the pill lost an average of 14% to 17% of body weight, with about one in three people losing 20% or more
In the OASIS-4 trial, oral Wegovy (25 mg) demonstrated an average weight loss of approximately 13.6% from baseline at 64 weeks in adults without diabetes
Special Considerations for Women Over 40 or 50 While semaglutide produces similar results in women regardless of their age, those going through perimenopause or menopause may have additional health concerns to consider namely, the risk of muscle and bone loss
The 23-time Grand Slam champ is the new celebrity ambassador for telehealth company Ro specifically, the direct-to-patient healthcare platforms FDA-approved GLP-1 treatments, which reduce glucose levels among those with Type 2 diabetes and help support weight loss
"At Target, we're always looking for ways to make wellness more accessible and inspiring for our guests," said Amanda Nusz, Senior Vice President of Merchandising, Essentials & Beauty at Target
Understanding Semaglutide What are Ozempic and Wegovy
